[1] | Moncada PA, Montoya JG. Toxoplasmosis in the fetus and newborn: An update on prevalence, diagnosis and treatment[J]. Expert Rev Anti Infect Ther, 2012, 10(7): 815-828. | [2] | Kazemi Arababadi M, Abdollahi SH, Ramezani M, et al. A review of immunological and neuropsychobehavioral effects of latent toxoplasmosis on humans[J]. Parasite Immunol, 2024, 46(7): e13060. | [3] | Montoya JG, Liesenfeld O. Toxoplasmosis[J]. Lancet, 2004, 363(9425): 1965-1976. | [4] | Flegr J, Lenochová P, Hodny Z, et al. Fatal attraction phenomenon in humans: Cat odour attractiveness increased for Toxoplasma-infected men while decreased for infected women[J]. PLoS Negl Trop Dis, 2011, 5(11): e1389. | [5] | Flegr J, Markoš A. Masterpiece of epigenetic engineering―How Toxoplasma gondii reprogrammes host brains to change fear to sexual attraction[J]. Mol Ecol, 2014, 23(24): 5934-5936. | [6] | Kaushik M, Knowles SL, Webster JP. What makes a feline fatal in Toxoplasma gondii’s fatal feline attraction? Infected rats choose wild cats[J]. Integr Comp Biol, 2014, 54(2): 118-128. | [7] | Ingram WM, Goodrich LM, Robey EA, et al. Mice infected with low-virulence strains of Toxoplasma gondii lose their innate aversion to cat urine, even after extensive parasite clearance[J]. PLoS One, 2013, 8(9): e75246. | [8] | Meyer CJ, Cassidy KA, Stahler EE, et al. Parasitic infection increases risk-taking in a social, intermediate host carnivore[J]. Commun Biol, 2022, 5(1): 1180. | [9] | Dellacasa-Lindberg I, Hitziger N, Barragan A. Localized recrudescence of Toxoplasma infections in the central nervous system of immunocompromised mice assessed by in vivo bioluminescence imaging[J]. Microbes Infect, 2007, 9(11): 1291-1298. | [10] | Berenreiterová M, Flegr J, Kuběna AA, et al. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: Implications for the behavioral manipulation hypothesis[J]. PLoS One, 2011, 6(12): e28925. | [11] | Elsheikha HM, Büsselberg D, Zhu XQ. The known and missing links between Toxoplasma gondii and schizophrenia[J]. Metab Brain Dis, 2016, 31(4): 749-759. | [12] | Prandovszky E, Gaskell E, Martin H, et al. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism[J]. PLoS One, 2011, 6(9): e23866. | [13] | Miller MW. Dopamine as a multifunctional neurotransmitter in gastropod molluscs: An evolutionary hypothesis[J]. Biol Bull, 2020, 239(3): 189-208. | [14] | Webster JP, Lamberton PL, Donnelly CA, et al. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii’s ability to alter host behaviour[J]. Proc Biol Sci, 2006, 273(1589): 1023-1030. | [15] | Kar N, Misra B. Toxoplasma seropositivity and depression: A case report[J]. BMC Psychiatry, 2004, 4: 1. | [16] | Savitz J. The kynurenine pathway: A finger in every pie[J]. Mol Psychiatry, 2020, 25(1): 131-147. | [17] | Notarangelo FM, Wilson EH, Horning KJ, et al. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: Implications for schizophrenia[J]. Schizophr Res, 2014, 152(1): 261-267. | [18] | Walker AK, Wing EE, Banks WA, et al. Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice[J]. Mol Psychiatry, 2019, 24(10): 1523-1532. | [19] | Bisetegn H, Debash H, Ebrahim H, et al. Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta-analysis[J]. Health Sci Rep, 2023, 6(6): e1319. | [20] | Jauhar S, Johnstone M, McKenna PJ. Schizophrenia[J]. Lancet, 2022, 399(10323): 473-486. | [21] | Wang HL, Wang GH, Li QY, et al. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia[J]. Acta Psychiatr Scand, 2006, 114(1): 40-48. | [22] | Esshili A, Thabet S, Jemli A, et al. Toxoplasma gondii infection in schizophrenia and associated clinical features[J]. Psychiatry Res, 2016, 245: 327-332. | [23] | Guimarães AL, Richer Araujo Coelho D, Scoriels L, et al. Effects of Toxoplasma gondii infection on cognition, symptoms, and response to digital cognitive training in schizophrenia[J]. Schizophrenia, 2022, 8: 104. | [24] | Fuller Torrey E, Bartko JJ, Lun ZR, et al. Antibodies to Toxoplasma gondii in patients with schizophrenia: A meta-analysis[J]. Schizophr Bull, 2007, 33(3): 729-736. | [25] | Niebuhr DW, Millikan AM, Cowan DN, et al. Selected infectious agents and risk of schizophrenia among U.S. military personnel[J]. Am J Psychiatry, 2008, 165(1): 99-106. | [26] | Brown AS, Schaefer CA, Quesenberry CP Jr, et al. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring[J]. Am J Psychiatry, 2005, 162(4): 767-773. | [27] | Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: Analysis of filter paper blood samples obtained at birth[J]. Biol Psychiatry, 2007, 61(5): 688-693. | [28] | McGrath JJ, Lim CCW, Saha S. Cat ownership and schizophrenia-related disorders and psychotic-like experiences: A systematic review and meta-analysis[J]. Schizophr Bull, 2024, 50(3): 489-495. | [29] | Postolache TT, Wadhawan A, Rujescu D, et al. Toxoplasma gondii, suicidal behavior, and intermediate phenotypes for suicidal behavior[J]. Front Psychiatry, 2021, 12: 665682. | [30] | Zhang YF, Träskman-Bendz L, Janelidze S, et al. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence[J]. J Clin Psychiatry, 2012, 73(8): 1069-1076. | [31] | Okusaga O, Langenberg P, Sleemi A, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia[J]. Schizophr Res, 2011, 133(1/2/3): 150-155. | [32] | Demirel ÖF, Akgül Ö, Bulu E, et al. Are bipolar disorder, major depression, and suicidality linked with Toxoplasma gondii? A seromolecular case-control study[J]. Postgrad Med, 2023, 135(2): 179-186. | [33] | Yang LL, Wang BY, Wu SZ, et al. Population-based cohort study of Toxoplasma gondii P22 antibody positivity correlation with anxiety[J]. J Affect Disord, 2024, 359: 41-48. | [34] | Akaltun İ, Kara SS, Kara T. The relationship between Toxoplasma gondii IgG antibodies and generalized anxiety disorder and obsessive-compulsive disorder in children and adolescents: A new approach[J]. Nord J Psychiatry, 2018, 72(1): 57-62. | [35] | Alvarado-Esquivel C, Sanchez-Anguiano LF, Hernandez-Tinoco J, et al. Toxoplasma gondii infection and mixed anxiety and depressive disorder: A case-control seroprevalence study in Durango, Mexico[J]. J Clin Med Res, 2016, 8(7): 519-523. | [36] | Nayeri Chegeni T, Sarvi S, Amouei A, et al. Relationship between toxoplasmosis and obsessive compulsive disorder: A systematic review and meta-analysis[J]. PLoS Negl Trop Dis, 2019, 13(4): e0007306. | [37] | Gajewski PD, Falkenstein M, Hengstler JG, et al. Toxoplasma gondii impairs memory in infected seniors[J]. Brain Behav Immun, 2014, 36: 193-199. | [38] | Rensch P, Postolache TT, Dalkner N, et al. Toxoplasma gondii IgG serointensity and cognitive function in bipolar disorder[J]. Int J Bipolar Disord, 2024, 12(1): 31. | [39] | Havlícek J, Gasová ZG, Smith AP, et al. Decrease of psychomotor performance in subjects with latent ‘asymptomatic’ toxoplasmosis[J]. Parasitology, 2001, 122(Pt 5): 515-520. | [40] | Rostagno AA. Pathogenesis of Alzheimer’s disease[J]. Int J Mol Sci, 2022, 24(1): 107. | [41] | Nayeri Chegeni T, Sarvi S, Moosazadeh M, et al. Is Toxoplasma gondii a potential risk factor for Alzheimer’s disease? A systematic review and meta-analysis[J]. Microb Pathog, 2019, 137: 103751. | [42] | Wang J, Lin P, Li D, et al. Analysis of the correlation between Toxoplasma gondii seropositivity and Alzheimer's disease[J]. Pathogens, 2024, 13(11): 1021. | [43] | Nayeri T, Sarvi S, Sharif M, et al. Toxoplasma gondii: A possible etiologic agent for Alzheimer’s disease[J]. Heliyon, 2021, 7(6): e07151. | [44] | Galeh TM, Ghazvini H, Mohammadi M, et al. Effects of diverse Types of Toxoplasma gondii on the outcome of Alzheimer’s disease in the rat model[J]. Microb Pathog, 2023, 174: 105931. | [45] | Jung BK, Pyo KH, Shin KY, et al. Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer’s disease[J]. PLoS One, 2012, 7(3): e33312. | [46] | MÖhle L, Israel N, Paarmann K, et al. Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes[J]. Acta Neuropathol Commun, 2016, 4: 25. | [47] | Yereli K, Balcioğlu IC, Ozbilgin A. Is Toxoplasma gondii a potential risk for traffic accidents in Turkey?[J]. Forensic Sci Int, 2006, 163(1/2): 34-37. | [48] | Galván-Ramírez MD, Sánchez-Orozco LV, Rodríguez LR, et al. Seroepidemiology of Toxoplasma gondii infection in drivers involved in road traffic accidents in the metropolitan area of Guadalajara, Jalisco, Mexico[J]. Parasit Vectors, 2013, 6(1): 294. | [49] | Stepanova EV, Kondrashin AV, Sergiev VP, et al. Significance of chronic toxoplasmosis in epidemiology of road traffic accidents in Russian Federation[J]. PLoS One, 2017, 12(9): e0184930. | [50] | Flegr J, Havlícek J, Kodym P, et al. Increased risk of traffic accidents in subjects with latent toxoplasmosis: A retrospective case-control study[J]. BMC Infect Dis, 2002, 2: 11. | [51] | Gohardehi S, Sharif M, Sarvi S, et al. The potential risk of toxoplasmosis for traffic accidents: A systematic review and meta-analysis[J]. Exp Parasitol, 2018, 191: 19-24. | [52] | Wohlfert EA, Blader IJ, Wilson EH. Brains and brawn: Toxoplasma infections of the central nervous system and skeletal muscle[J]. Trends Parasitol, 2017, 33(7): 519-531. | [53] | Cook TB, Brenner LA, Robert Cloninger C, et al. “Latent” infection with Toxoplasma gondii: Association with trait aggression and impulsivity in healthy adults[J]. J Psychiatr Res, 2015, 60: 87-94. | [54] | Flegr J, Preiss M, Klose J, et al. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii dopamine, a missing link between schizophrenia and toxoplasmosis?[J]. Biol Psychol, 2003, 63(3): 253-268. | [55] | Abdoli A, Ghaffarifar F, Sharifi Z, et al. Toxoplasma gondii infection and testosterone alteration: A systematic review and meta-analyses[J]. PLoS One, 2024, 19(4): e0297362. | [56] | Lim A, Kumar V, Hari Dass SA, et al. Toxoplasma gondii infection enhances testicular steroidogenesis in rats[J]. Mol Ecol, 2013, 22(1): 102-110. | [57] | Dass SAH, Vasudevan A, Dutta D, et al. Protozoan parasite Toxoplasma gondii manipulates mate choice in rats by enhancing attractiveness of males[J]. PLoS One, 2011, 6(11): e27229. | [58] | Roy AK, Neuhaus OW. Proof of the hepatic synthesis of a sex-dependent protein in the rat[J]. Biochim Biophys Acta, 1966, 127(1): 82-87. | [59] | Vasudevan A, Kumar V, Chiang YN, et al. α2u-globulins mediate manipulation of host attractiveness in Toxoplasma gondii-Rattus novergicus association[J]. ISME J, 2015, 9(9): 2112-2115. | [60] | Borráz-León JI, Rantala MJ, Krams IA, et al. Are Toxoplasma-infected subjects more attractive, symmetrical, or healthier than non-infected ones? Evidence from subjective and objective measurements[J]. PeerJ, 2022, 10: e13122. | [61] | Cuffey J, Lepczyk CA, Zhao SL, et al. Cross-sectional association of Toxoplasma gondii exposure with BMI and diet in US adults[J]. PLoS Negl Trop Dis, 2021, 15(10): e0009825. | [62] | Belluco S, Mancin M, Conficoni D, et al. Investigating the determinants of Toxoplasma gondii prevalence in meat: A systematic review and meta-regression[J]. PLoS One, 2016, 11(4): e0153856. | [63] | Reeves GM, Mazaheri S, Snitker S, et al. A positive association between T. gondii seropositivity and obesity[J]. Front Public Health, 2013, 1: 73. | [64] | Pleyer U, Gross U, Schlüter D, et al. Toxoplasmosis in Germany[J]. Dtsch Arztebl Int, 2019, 116(25): 435-444. |
|